A detailed history of Bailard, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Bailard, Inc. holds 76,473 shares of ABT stock, worth $8.86 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
76,473
Previous 76,792 0.42%
Holding current value
$8.86 Million
Previous $7.98 Million 9.26%
% of portfolio
0.23%
Previous 0.22%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $31,922 - $37,683
-319 Reduced 0.42%
76,473 $8.72 Million
Q2 2024

Jul 25, 2024

SELL
$100.73 - $112.44 $43,011 - $48,011
-427 Reduced 0.55%
76,792 $7.98 Million
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $3,504 - $3,870
-32 Reduced 0.04%
77,219 $8.78 Million
Q4 2023

Feb 02, 2024

SELL
$90.19 - $110.4 $30,123 - $36,873
-334 Reduced 0.43%
77,251 $8.5 Million
Q3 2023

Oct 24, 2023

BUY
$95.53 - $114.62 $696,986 - $836,267
7,296 Added 10.38%
77,585 $7.51 Million
Q2 2023

Jul 20, 2023

SELL
$100.78 - $112.29 $704,552 - $785,019
-6,991 Reduced 9.05%
70,289 $7.66 Million
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $44,943 - $52,900
-464 Reduced 0.6%
77,280 $7.83 Million
Q4 2022

Feb 02, 2023

SELL
$95.06 - $111.52 $104,756 - $122,895
-1,102 Reduced 1.4%
77,744 $8.54 Million
Q3 2022

Oct 18, 2022

BUY
$96.76 - $112.03 $33,285 - $38,538
344 Added 0.44%
78,846 $7.63 Million
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $140,550 - $169,880
-1,377 Reduced 1.72%
78,502 $8.53 Million
Q1 2022

Apr 25, 2022

SELL
$114.02 - $139.04 $51,194 - $62,428
-449 Reduced 0.56%
79,879 $9.46 Million
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $24,607 - $30,130
213 Added 0.27%
80,328 $11.3 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $17,499 - $19,359
150 Added 0.19%
80,115 $9.46 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $378,305 - $445,319
-3,576 Reduced 4.28%
79,965 $9.27 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $7.01 Million - $8.26 Million
64,386 Added 336.13%
83,541 $10 Million
Q4 2020

Feb 03, 2021

BUY
$105.0 - $114.42 $235,305 - $256,415
2,241 Added 13.25%
19,155 $2.1 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $88,615 - $107,617
967 Added 6.06%
16,914 $1.84 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $50,229 - $64,288
656 Added 4.29%
15,947 $1.46 Million
Q1 2020

Apr 16, 2020

SELL
$62.82 - $91.86 $22,363 - $32,702
-356 Reduced 2.28%
15,291 $1.21 Million
Q4 2019

Jan 31, 2020

BUY
$78.51 - $87.4 $2,512 - $2,796
32 Added 0.2%
15,647 $1.36 Million
Q3 2019

Oct 18, 2019

SELL
$81.84 - $88.74 $3,273 - $3,549
-40 Reduced 0.26%
15,615 $1.31 Million
Q2 2019

Jul 26, 2019

SELL
$72.88 - $85.0 $5,830 - $6,800
-80 Reduced 0.51%
15,655 $1.32 Million
Q1 2019

Apr 24, 2019

BUY
$66.22 - $80.06 $95,290 - $115,206
1,439 Added 10.07%
15,735 $1.26 Million
Q4 2018

Feb 05, 2019

BUY
$65.56 - $74.27 $54,283 - $61,495
828 Added 6.15%
14,296 $1.03 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $86,775 - $104,684
1,427 Added 11.85%
13,468 $988,000
Q2 2018

Aug 08, 2018

SELL
$57.57 - $63.54 $18,422 - $20,332
-320 Reduced 2.59%
12,041 $734,000
Q1 2018

May 07, 2018

SELL
$56.27 - $63.62 $24,477 - $27,674
-435 Reduced 3.4%
12,361 $741,000
Q4 2017

Feb 08, 2018

BUY
$53.68 - $57.47 $16,104 - $17,241
300 Added 2.4%
12,796 $0
Q3 2017

Oct 11, 2017

SELL
$48.06 - $53.64 $12,015 - $13,410
-250 Reduced 1.96%
12,496 $667,000
Q2 2017

Aug 11, 2017

SELL
N/A
-1,865 Reduced 12.76%
12,746 $0
Q1 2017

Jan 29, 2018

BUY
N/A
51 Added 0.35%
14,611 $649,000
Q4 2016

Jan 29, 2018

SELL
N/A
-2,024 Reduced 12.2%
14,560 $0
Q3 2016

Jan 29, 2018

BUY
N/A
6,248 Added 60.45%
16,584 $701,000
Q2 2016

Jan 29, 2018

BUY
N/A
3,687 Added 55.45%
10,336 $0
Q1 2016

Jan 29, 2018

SELL
N/A
-448 Reduced 6.31%
6,649 $278,000
Q3 2015

Jan 29, 2018

SELL
N/A
-803 Reduced 10.16%
7,097 $285,000
Q2 2015

Jan 29, 2018

SELL
N/A
-80 Reduced 1.0%
7,900 $0
Q1 2015

Jan 29, 2018

BUY
N/A
458 Added 6.09%
7,980 $370,000
Q4 2014

Jan 29, 2018

BUY
N/A
7,522
7,522 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.